NO175266C - Fremgangsmåte for fremstilling av et humant t-PA protein som mangler en eller flere av de N-bundne karbohydratrestene, DNA, hybridvektor samt transformert eukaryot vertscelle som er i stand til å uttrykke et humant t-PA protein - Google Patents

Fremgangsmåte for fremstilling av et humant t-PA protein som mangler en eller flere av de N-bundne karbohydratrestene, DNA, hybridvektor samt transformert eukaryot vertscelle som er i stand til å uttrykke et humant t-PA protein

Info

Publication number
NO175266C
NO175266C NO864569A NO864569A NO175266C NO 175266 C NO175266 C NO 175266C NO 864569 A NO864569 A NO 864569A NO 864569 A NO864569 A NO 864569A NO 175266 C NO175266 C NO 175266C
Authority
NO
Norway
Prior art keywords
human
protein
expressing
dna
producing
Prior art date
Application number
NO864569A
Other languages
English (en)
Norwegian (no)
Other versions
NO864569D0 (no
NO175266B (no
NO864569L (no
Inventor
Bhabatosh Chaudhuri
Bernd Meyhack
Jutta Heim
Jan Van Oostrum
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO864569D0 publication Critical patent/NO864569D0/no
Publication of NO864569L publication Critical patent/NO864569L/no
Publication of NO175266B publication Critical patent/NO175266B/no
Publication of NO175266C publication Critical patent/NO175266C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
NO864569A 1985-11-18 1986-11-17 Fremgangsmåte for fremstilling av et humant t-PA protein som mangler en eller flere av de N-bundne karbohydratrestene, DNA, hybridvektor samt transformert eukaryot vertscelle som er i stand til å uttrykke et humant t-PA protein NO175266C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858528321A GB8528321D0 (en) 1985-11-18 1985-11-18 Modified fibrinolytic agents

Publications (4)

Publication Number Publication Date
NO864569D0 NO864569D0 (no) 1986-11-17
NO864569L NO864569L (no) 1987-05-19
NO175266B NO175266B (no) 1994-06-13
NO175266C true NO175266C (no) 1994-09-28

Family

ID=10588363

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864569A NO175266C (no) 1985-11-18 1986-11-17 Fremgangsmåte for fremstilling av et humant t-PA protein som mangler en eller flere av de N-bundne karbohydratrestene, DNA, hybridvektor samt transformert eukaryot vertscelle som er i stand til å uttrykke et humant t-PA protein

Country Status (17)

Country Link
EP (1) EP0225286B1 (de)
JP (1) JPS62272976A (de)
KR (1) KR920007666B1 (de)
AT (1) ATE78514T1 (de)
AU (1) AU598490B2 (de)
DE (1) DE3686136T2 (de)
DK (1) DK174977B1 (de)
ES (1) ES2043607T3 (de)
FI (1) FI91160C (de)
GB (1) GB8528321D0 (de)
GR (1) GR3006041T3 (de)
IE (1) IE57866B1 (de)
IL (1) IL80659A (de)
NO (1) NO175266C (de)
NZ (1) NZ218305A (de)
PT (1) PT83752B (de)
ZA (1) ZA868689B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK175327B1 (da) * 1984-10-01 2004-08-23 Integrated Genetics Inc Replicerbar ekspressionsvektor og rekombinant DNA-molekyle, som indkoder aktiv human livmodervævsplasminogen-aktivator, pattedyrscelle transformeret med vektoren og fremgangsmåde til fremstilling af aktiv human vævsplasminogen-aktivator (TPA)
DK623186A (da) * 1985-12-23 1987-08-26 Chiron Corp Polypeptid med vaevsplasminogen-aktivator-virkning
US5837518A (en) * 1986-01-31 1998-11-17 Genetics Institute, Inc. Thrombolytic proteins
US5258298A (en) * 1986-01-31 1993-11-02 Genetics Institute, Inc. Deletion and glycosylation mutant of human tissue plasminogen activator
US5002887A (en) * 1986-01-31 1991-03-26 Genetics Institute, Inc. Truncated thrombolytic proteins
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation
US5589361A (en) * 1986-03-18 1996-12-31 Genentech, Inc. Human tissue-type plasminogen activator variant
US5047241A (en) * 1986-07-11 1991-09-10 American Home Products Corporation Tris-Kringle plasminogen activator with novel K2 insert
EP0276846A3 (de) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Derivate des koloniestimulierenden Faktors
JPH084501B2 (ja) * 1987-03-20 1996-01-24 エーザイ株式会社 糖鎖に関する変異tPA
SE8702562L (sv) * 1987-06-18 1988-12-19 Kabigen Ab Nya fibrinolytiska enzymer
US6682733B1 (en) * 1987-06-18 2004-01-27 Roche Diagnostics, Gmbh Fibrinolytic enzymes
US5266474A (en) * 1987-06-24 1993-11-30 Genentech, Inc. Balanced inducible transcription system
US5302390A (en) * 1987-07-01 1994-04-12 Beecham Group Plc Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment
EP0394261A4 (en) * 1987-07-06 1991-09-11 Genetics Institute, Inc. Novel thrombolytic proteins
AU1893988A (en) * 1987-07-13 1989-01-19 Collaborative Research Inc. Nonglycosylated plasminogen activator and method of preparation
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5346824A (en) * 1988-05-20 1994-09-13 Genentech, Inc. DNA encoding variants of tissue plasminogen activators and expression vectors and hosts thereof
IL90146A (en) * 1988-05-20 1994-10-07 Genentech Inc Glycosylation derivatives of tissue plasminogen activator
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5258180A (en) * 1988-09-02 1993-11-02 Genetech, Inc. Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
WO1991015235A1 (en) * 1990-03-30 1991-10-17 Survival Technology, Inc. t-PA ENHANCER PROFILE
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
DE69333127T2 (de) * 1992-06-03 2004-05-06 Genentech, Inc., South San Francisco Varianten des Gewebeplasminogenaktivators mit verbesserter therapeutischer Wirkung
US5661001A (en) * 1993-08-04 1997-08-26 Ciba-Geigy Corporation High molecular weight desulphatohirudin
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
PT2861614T (pt) * 2012-06-14 2017-01-26 Portola Pharm Inc Método para a purificação de derivados do fator xa recombinantes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1662352A3 (ru) * 1982-05-05 1991-07-07 Генентек, Инк (Фирма) Штамм бактерий ЕSснеRIснIа coLI - продуцент активатора плазминогена тканевого типа
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
EP0125254A1 (de) * 1982-10-28 1984-11-21 Beecham Group Plc Enzymderivate und deren verwendung bei der behandlung von trombosen
AU572108B2 (en) * 1983-01-19 1988-05-05 Genentech Inc. Human tpa production using vectors coding for dhfr protein
DK175327B1 (da) * 1984-10-01 2004-08-23 Integrated Genetics Inc Replicerbar ekspressionsvektor og rekombinant DNA-molekyle, som indkoder aktiv human livmodervævsplasminogen-aktivator, pattedyrscelle transformeret med vektoren og fremgangsmåde til fremstilling af aktiv human vævsplasminogen-aktivator (TPA)
DE3537176C2 (de) * 1984-10-18 1994-06-09 Zymogenetics Inc Gewebeplasminogenaktivator und Verfahren zu seiner Herstellung
JPH0811066B2 (ja) * 1985-09-30 1996-02-07 インテグレーテッド・ジエネティックス・インコーポレーテッド 組換えdnaが生産するヒト子宮プラスミノ−ゲンアクチベ−タ−

Also Published As

Publication number Publication date
GB8528321D0 (en) 1985-12-24
FI91160C (fi) 1994-05-25
DK549186D0 (da) 1986-11-17
NO864569D0 (no) 1986-11-17
ZA868689B (en) 1987-06-24
IE57866B1 (en) 1993-05-05
PT83752A (en) 1986-12-01
JPS62272976A (ja) 1987-11-27
EP0225286B1 (de) 1992-07-22
PT83752B (pt) 1989-06-30
KR920007666B1 (ko) 1992-09-14
FI864654L (fi) 1987-05-19
ATE78514T1 (de) 1992-08-15
KR870005094A (ko) 1987-06-04
IL80659A0 (en) 1987-02-27
NZ218305A (en) 1990-01-29
IL80659A (en) 1991-12-15
DK174977B1 (da) 2004-04-05
AU598490B2 (en) 1990-06-28
NO175266B (no) 1994-06-13
GR3006041T3 (de) 1993-06-21
NO864569L (no) 1987-05-19
EP0225286A2 (de) 1987-06-10
DK549186A (da) 1987-05-19
DE3686136T2 (de) 1992-12-17
FI864654A0 (fi) 1986-11-14
DE3686136D1 (de) 1992-08-27
FI91160B (fi) 1994-02-15
AU6520086A (en) 1987-05-21
IE863028L (en) 1987-05-18
ES2043607T3 (es) 1994-01-01
EP0225286A3 (en) 1987-10-07

Similar Documents

Publication Publication Date Title
FI864654A0 (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
EP0244234A3 (en) Transformation of trichoderma
DE58909780D1 (de) Unter Verwendung von Alkenyl-phosphon- und -phosphinsäureester als Vernetzer hergestellte Hydrogele.
DK247084A (da) 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer, fremgangsmaader til deres fremstilling samt antibakterielle midler indeholdende disse
AU8006887A (en) Stabilized enzyme system for use in aqueous liquid built detergent compositions
FI885679A0 (fi) Samuttryckning i eukariotiska celler.
ATE142264T1 (de) Rekombinante herstellung von a-ketten- polypeptiden von pdgf
NO177603C (no) Fremgangsmåte for fremstilling av hybride proteiner, DNA sekvens, hybridvektor og eukaryot vertscelle
NO177793C (no) Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten
AU7017887A (en) Cr-doped scandium borate laser
ZA892744B (en) Method for the preparation of zeolites
AU590076B2 (en) Beam steering unit real time angular monitor
GR3007909T3 (de)
PL306291A1 (en) C-protein obtaining method
AU604122B2 (en) An episomal vector for the expression of selected dna fragments coding for polypeptides in mammalian cells and methods for the production thereof
PT93300A (pt) Processo para a sintese de proteinas utilizando vectores de expressao na levedura de cisao schizosaccharomyces pombe
AU7963487A (en) Recombinant ligninase
ES2187514T3 (es) Colesterol-7-alfa-hidroxilasa humana truncada, metodo de produccion y uso de la misma.
NO175434C (no) Rekombinant DNA-vektor, pattedyrcelle transformert med denne samt fremgangsmåte for fremstilling av human plasminogenaktivator
AU4967190A (en) Method of obtaining human-interleukin-2 polypeptide in yeast cells
BR8603894A (pt) Metodo simplificado r.k.m.de aprendizado dinamico em datilografia

Legal Events

Date Code Title Description
MK1K Patent expired